Note: Ingredients listed on restricted chemical lists
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0.001
General Information
Version
12.1
Revision date
2024-06-28
Product name
SPARKLE
1.2.1 Relevant identified uses
Professional use,Industrial use Industrial/Professional use spec Industrial
Emergency telephone
+353 1 809 2566, +353 1 809 2166, 0344 892 0111
Icons in SDS
Company Information
company name
The Clean Machine Direct Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@thecleanmachine.co.uk
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Precautionary statements
P102 - Keep out of reach of children. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Supplemental label elements
EUH208 - Contains METHYLCHLOROISOTHIAZOLINONE (AND) METHYLISOTHIAZOLINONE. May produce an allergic reaction.
2.3 Other hazards
This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Adverse physicochemical, human health and environmental effects No additional information available
